Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Singer

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Molecular & Cellular Proteomics : MCP|January 25, 2018
Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC)Katarzyna Buczak, Alessandro Ori, Joanna M Kirkpatrick, et al.
The Journal of Clinical Investigation|October 28, 2010
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cellsUta Kossatz, Kai Breuhahn, Benita Wolf, et al.
Cancers|March 10, 2022
STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular CarcinomaCarolin Ploeger, Johannes Schreck, Thorben Huth, et al.
BMC Biology|August 3, 2018
Species comparison of liver proteomes reveals links to naked mole-rat longevity and human agingIvonne Heinze, Martin Bens, Enrico Calzia, et al.
Oncogene|April 3, 2019
YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cellsTeng Wei, Sofia Maria Elisabeth Weiler, Marcell Tóth, et al.
Nature Reviews. Endocrinology|October 21, 2021
Metabolic implications of pancreatic fat accumulationRobert Wagner, Sabine S Eckstein, Hajime Yamazaki, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
Cancers|January 21, 2022
HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1Stefanie Schuller, Jan Sieker, Philip Riemenschneider, et al.
Theranostics|February 7, 2024
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-NOTA-ch14.18/CHONils Florian Trautwein, Johannes Schwenck, Christian Seitz, et al.
Cancer Research|March 5, 2009
Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancerStephan Singer, Mona Malz, Esther Herpel, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Molecular & Cellular Proteomics : MCP|January 25, 2018
Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC)Katarzyna Buczak, Alessandro Ori, Joanna M Kirkpatrick, et al.
The Journal of Clinical Investigation|October 28, 2010
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cellsUta Kossatz, Kai Breuhahn, Benita Wolf, et al.
Cancers|March 10, 2022
STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular CarcinomaCarolin Ploeger, Johannes Schreck, Thorben Huth, et al.
BMC Biology|August 3, 2018
Species comparison of liver proteomes reveals links to naked mole-rat longevity and human agingIvonne Heinze, Martin Bens, Enrico Calzia, et al.
Oncogene|April 3, 2019
YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cellsTeng Wei, Sofia Maria Elisabeth Weiler, Marcell Tóth, et al.
Nature Reviews. Endocrinology|October 21, 2021
Metabolic implications of pancreatic fat accumulationRobert Wagner, Sabine S Eckstein, Hajime Yamazaki, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
Cancers|January 21, 2022
HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1Stefanie Schuller, Jan Sieker, Philip Riemenschneider, et al.
Theranostics|February 7, 2024
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-NOTA-ch14.18/CHONils Florian Trautwein, Johannes Schwenck, Christian Seitz, et al.
Cancer Research|March 5, 2009
Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancerStephan Singer, Mona Malz, Esther Herpel, et al.
Pageof 10